Bristol Myers Squibb (CELG-RI) Dividends Paid - Common (2009 - 2026)

Bristol Myers Squibb (CELG-RI) reported Dividends Paid - Common of $1.3 billion for Q1 2026, up 1.99% year-over-year from $1.3 billion in Q1 2025, and up 1.66% quarter-over-quarter from $1.3 billion in Q4 2025.

Bristol Myers Squibb (CELG-RI) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has 18 years of Dividends Paid - Common data on file, last reported at $1.3 billion in Q1 2026.

  • Dividends Paid - Common for Q1 2026 came in at $1.3 billion, up 1.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 3.28% YoY), and the FY2025 annual result was $5.0 billion, up 3.74% from the prior year.
  • Dividends Paid - Common climbed to $1.3 billion in Q1 2026 per CELG-RI's latest filing, from $1.3 billion in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $1.3 billion in Q1 2026 and troughed at $12.0 million in Q2 2022.
  • A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Dividends Paid - Common.
  • On a YoY basis, Dividends Paid - Common climbed as much as 9875.0% in 2023 and fell as far as 0.93% in 2023.
  • A 5-year view of Dividends Paid - Common shows it stood at $1.1 billion in 2022, then rose by 1.31% to $1.2 billion in 2023, then rose by 5.0% to $1.2 billion in 2024, then climbed by 3.61% to $1.3 billion in 2025, then grew by 1.66% to $1.3 billion in 2026.
  • Business Quant data shows CELG-RI's Dividends Paid - Common at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -866.88 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 1.55 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 3.13 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 3.09 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 2.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.04 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.45 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.28 Bn
10 Bristol Myers Squibb - - 8.07 Bn 1.28 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Bn
Mar 31, 2026 1.28 Bn
Dec 31, 2025 1.26 Bn
Dec 31, 2025 1.26 Bn
Sep 30, 2025 1.26 Bn
Sep 30, 2025 1.26 Bn
Jun 30, 2025 1.26 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.26 Bn
Mar 31, 2025 1.26 Bn
Dec 31, 2024 1.22 Bn
Dec 31, 2024 1.22 Bn
Sep 30, 2024 1.22 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.22 Bn
Jun 30, 2024 1.22 Bn
Mar 31, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.16 Bn
Dec 31, 2023 1.16 Bn